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Inflammatory cells may contribute to secondary brain injury following cerebral ischemia.
The C57Bl/6 mouse strain is known to exhibit a T helper 1-prone, pro-inflammatory
type response to injury, whereas the FVB strain is relatively T helper 2-prone, or
anti-inflammatory, in its immune response. We tested whether stroke outcome is more
severe in C57Bl/6 than FVB mice. Male mice of each strain underwent sham surgery or
1 h occlusion of the middle cerebral artery followed by 23h of reperfusion. Despite no
difference in infarct size, C57Bl/6 mice displayed markedly greater functional deficits than
FVB mice after stroke, as assessed by neurological scoring and hanging wire test. Total
numbers of CD45+ leukocytes tended to be larger in the brains of C57Bl/6 than FVB mice
after stroke, but there were marked differences in leukocyte composition between the
two mouse strains. The inflammatory response in C57Bl/6 mice primarily involved T and B
lymphocytes, whereas neutrophils, monocytes and macrophages were more prominent in
FVB mice. Our data are consistent with the concept that functional outcome after stroke
is dependent on the immune cell composition which develops following ischemic brain
injury.
Keywords: cerebral ischemia-reperfusion, immune cell infiltration, inflammation, middle cerebral artery occlusion,
stroke, Th1/Th2 balance
INTRODUCTION
Stroke is the 4th leading cause of death after heart disease, cancer
and chronic lower respiratory disease, and over a third of sur-
vivors are left with major neurological injury (Go et al., 2013).
Approximately 85% of stroke cases are of the ischemic type (Go
et al., 2013), in which an embolus or local thrombus causes occlu-
sion of a major cerebral artery and results in disruption of brain
blood flow. Whilst thrombolysis by intravenous recombinant tis-
sue plasminogen activator (rt-PA) may be effective in improving
outcome by promoting reperfusion, it has a number of limita-
tions, including a short therapeutic window of 3–4.5 h (<10%
of stroke patients receive rt-PA) (Gravanis and Tsirka, 2008).
For further advances in the clinical treatment of ischemic stroke,
the complex mechanisms of cellular injury following cerebral
ischemia must be elucidated to provide novel targets for future
therapies.
It is now established that the initial insult in ischemic stroke
is followed by induction of cytokines and chemokines, which
attract numerous inflammatory cell types to the damaged brain
region, which ultimately contribute to secondary brain injury
(Gelderblom et al., 2009; Chu et al., 2014). Growing evidence
indicates the importance of T lymphocytes in cerebral ischemic
damage, whereby they become activated and infiltrate the brain
within 24 h (Yilmaz et al., 2006; Hurn et al., 2007; Urra et al.,
2009a), although the mechanism(s) underlying their actions are
not fully clear. Recombination activating gene 1-deficient mice,
which lack T and B lymphocytes, have less severe brain injury
following cerebral ischemia, and this protection is lost upon
reconstitution with T but not B lymphocytes (Yilmaz et al., 2006;
Kleinschnitz et al., 2010).
T lymphocytes (CD3+ cells) are mostly comprised of CD4+
T helper (Th) and CD8+ cytotoxic T (Tc) cell subpopulations,
both of which are thought to play detrimental roles in ischemic
stroke (Yilmaz et al., 2006). There is also evidence that regula-
tory T lymphocytes (Tregs; CD4+CD25+FoxP3+) may modulate
the severity of stroke outcome (Liesz et al., 2009), despite exerting
acutely detrimental effects by promoting intravascular coagula-
tion during reperfusion (Kleinschnitz et al., 2013). Major distinct
Th cell types include Th1 and Th2, and are defined accord-
ing to the cytokines they release (Abbas et al., 1996). In general
terms, Th1 cells promote an inflammatory response through
secretion of pro-inflammatory cytokines [e.g., interleukin(IL)-
2, IL-12, interferon(IFN)-γ, and tumor necrosis factor(TNF)-α],
whereas Th2 cells promote a humoral or allergic response by
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secretion of anti-inflammatory cytokines (e.g., IL-4, IL-10, and
IL-13) (Arumugam et al., 2005; Jin et al., 2010).
Clarification of the importance of Th1 and Th2 immunity in
acute stroke is needed to define the complex evolution of cere-
bral ischemic injury and potentially identify therapeutic strate-
gies to limit stroke injury. Here, we have studied representative
mouse strains commonly accepted as Th1-dominant (C57Bl/6)
and Th2-dominant (FVB) (Whitehead et al., 2003) to investigate
stroke outcome in a prototypical Th1- or Th2-prone immune
environment, respectively.
MATERIALS AND METHODS
ANIMALS
This study fully adheres to the Animal Research: Reporting In
Vivo Experiments (ARRIVE) guidelines (Kilkenny et al., 2010).
All animal experiments were conducted in accordance with
National Health andMedical Research Council of Australia guide-
lines for the care and use of animals in research and approved
by the Monash University Animal Ethics Committee (Projects
SOBSB/2010/10 and SOBSB/2011/112). A total of 201 male mice
(C57Bl/6: n = 89, 19–33 g; FVB: n = 112, 25–39 g) aged 8–15
weeks were studied. The mice had free access to water and food
pellets before and after surgery. Thirty-seven mice were excluded
from the study because they: (1) died during surgical procedure
(C57Bl/6: n = 12; FVB: n = 24) or (2) were euthanized prior
to 24 h as per institutional ethics requirements due to severe
functional impairment (C57Bl/6: n = 1).
TRANSIENT FOCAL CEREBRAL ISCHEMIA
Focal cerebral ischemia was induced by transient intraluminal fil-
ament occlusion of the right middle cerebral artery (MCA) as
described previously (Jackman et al., 2009; Brait et al., 2010).
Mice were anesthetized with ketamine-xylazine (80 and 10mg/kg,
respectively; intraperitoneal). Rectal temperature was monitored
and maintained at 37.5 ± 0.5◦C throughout the procedure and
until animals regained consciousness using an electronic temper-
ature controller (Testronics, Kinglake, Victoria, Australia) linked
to a heat lamp. The right proximal common carotid artery was
clamped, and a 6–0 nylon monofilament with silicone-coated
tip (Doccol Co., Redlands, CA, USA) was inserted and gently
advanced into the distal internal carotid artery, 11–12mm dis-
tal to the carotid bifurcation, occluding the MCA at the junction
of the Circle of Willis. Severe (∼80%) reduction in regional
cerebral blood flow (rCBF) was confirmed using transcranial
laser-Doppler flowmetry (Perimed, Järfälla, Sweden) in the area
of cerebral cortex supplied by the MCA. The filament was then
tied in place and the clamp was removed. After 1 h of cerebral
ischemia, the monofilament was retracted to allow reperfusion
for 23 h. Reperfusion was confirmed by an immediate increase
in rCBF, which reached the pre-ischemic level within 5min. The
wound was then closed and the animal was allowed to recover.
Regional CBF was recorded for 30min after the induction of
reperfusion. Sham-operated mice were anesthetized and the right
carotid bifurcation was exposed, dissected free from surrounding
connective tissue but no filament was inserted. All animals were
administered 1mL of sterile saline via a subcutaneous injection
for rehydration after surgery.
NEUROLOGICAL ASSESSMENT
At the end of the experiment (24 h after induction of stroke/sham
surgery), neurological assessment was performed using a modi-
fied six-point scoring system (Jackman et al., 2009; Brait et al.,
2010): 0, normalmotor function; 1, flexion of torso and contralat-
eral forelimb when mouse is lifted by the tail; 2, circling when
mouse held by the tail on a flat surface; 3, leaning to the one side
at rest; 4, no spontaneous motor activity; 5, death within 24 h.
A hanging wire test was also performed in which mice were sus-
pended from a wire 30 cm high for up to 180 s, and the average
time of 3 trials with 5-min rest periods in between was recorded.
Neurological assessment was evaluated by an observer blinded to
experimental groups.
CEREBRAL INFARCT AND EDEMA VOLUMES
Mice were killed at 24 h by inhalation of isoflurane, followed by
decapitation. The brains were immediately removed and snap
frozen with liquid nitrogen. Coronal sections (30μm) separated
by ∼420μm were obtained and stained with thionin (0.1%)
to delineate the infarct. Images of the sections were captured
with a CCD camera mounted above a light box. Infarct vol-
ume was quantified as described previously (Jackman et al., 2009;
Kim et al., 2012) using image analysis software (ImageJ, NIH,
Bethesda, MD, USA), and corrected for brain edema, estimated
using the following formula: corrected infarct volume = [left
hemisphere area − (right hemisphere area − right hemisphere
infarct area) × (thickness of section + distance between sec-
tions)] (Tsuchiya et al., 2003; Xia et al., 2006). Edema-corrected
infarct volumes of individual brain sections were then added
giving a three-dimensional approximation of the total infarct
volume. Total, cortical and subcortical infarct volumes were
quantified individually.
GROSS CEREBROVASCULAR ANATOMY
For gross comparison of cerebrovascular anatomy, some naïve
animals (n = 3 of each strain, without any surgical procedures)
were deeply anesthetized by inhalation of isoflurane, the tho-
rax was opened and intracardial perfusion was performed with
PBS, followed by 4% paraformaldehyde and finally 4% Evans blue
solution in 20% gelatin.
FLOW CYTOMETRY
On each occasion when flow cytometry was utilized, we stud-
ied at least one post-stroke mouse together with a time-matched
sham-operated control mouse of each strain. Animals were euth-
anized at 24 h by inhalation of isoflurane, followed by blood
removal by cardiac puncture and the whole mouse was then
intracardially perfused with phosphate-buffered saline (PBS) and
brain, blood, and spleen were collected. Leukocytes were puri-
fied from blood using red blood cell lysis buffer (155mmol/L
NH4Cl, 10mmol/L KHCO3, and 3mmol/L EDTA). Spleens were
mechanically dissociated and passed through 70μm nylon cell
strainers (BD Falcon, Bedford, MA, USA) to obtain a single-cell
suspension. Cells were then lysed with red blood cell lysis buffer
and washed with PBS containing 1% bovine serum albumin. The
brain was removed from the skull and after removing the cerebel-
lum and olfactory bulb, was separated into left (contralateral) and
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right (ischemic) hemispheres. Each hemisphere was dissociated
mechanically in digestion buffer containing collagenase type XI
(125U/mL), hyaluronidase (60U/mL), and collagenase type I-S
(450U/mL) in Ca2+/Mg2+-supplemented PBS (Sigma, St Louis,
MO, USA), and incubated at 37◦C for 30min with gentle agi-
tation. The mixture was then passed through 70μm nylon cell
strainers to obtain a single-cell suspension. After washing with
PBS (1200 rpm, 10min), the cell pellet was resuspended in 3mL
30% percoll (GE Healthcare, Uppsala, Sweden), underlaid with
70% percoll, and centrifuged for 20min at 2400 rpm at room
temperature without the use of a brake. The cells at the inter-
phase of two density gradients were collected and washed with
PBS containing 1% bovine serum albumin (1200 rpm, 10min)
for staining. All cells were incubated with appropriate antibodies
listed in Table 1 at 4◦C in darkness for 20min. After staining, cells
were analyzed by LSRII flow cytometer (BD Biosciences, Franklin
Lakes, NJ, USA) and FlowJo software (Tree Star Inc., Ashland,
OR, USA). Countbright counting beads (Invitrogen, Carlsbad,
CA, USA) were included to define the absolute number of cells
in the samples.
GATING STRATEGY
Single cells were identified by forward scatter, and dead
cells (7-amino actinomycin D+) were excluded. Cells were
gated for CD45+high and CD45+med populations as described
previously (Chu et al., 2014). CD45+high populations were
then divided into lymphoid cells, which include: B cells
(B220+), T cells (CD49b+CD90−NK1.1−), thymocytes
(CD49b−CD90+NK1.1−), NK cells (CD49b+CD90+NK1.1+),
and NKT cells (CD49b+CD90−NK1.1+); and myeloid cells
(CD11b+). CD45+medCD11b+F4/80+ cells were considered
microglia. Two panels of antibodies were used, one of which
was employed with each animal. Panel 1 enabled the counting
of microglia and myeloid-derived leukocytes (i.e., CD11b+
cells), which include: neutrophils (Ly6G+), monocytes (Ly6C+),
macrophages (F4/80+), and dendritic cells (CD11c+); whereas
Table 1 | Summary of antibodies used for flow cytometry.
Antigen Host/Isotype Supplier
CD8a-APC Rat IgG2a, kappa BD Phamingen
CD19-PE Rat IgG2a, kappa BioLegend
CD11c-Brilliant Violet 570 ArHam IgG BioLegend
CD25-PE-Cy7 Rat IgG1, lambda BioLegend
CD4-FITC Rat IgG2b, kappa BioLegend
CD45-APC-Cy7 Rat IgG2b, kappa BioLegend
CD49b-PE ArHam IgG BioLegend
CD90.2-PE Rat IgG2b, kappa BioLegend
Ly6C-FITC Rat IgG2c, kappa BioLegend
Ly6G-PE-Cy7 Rat IgG2a, kappa BioLegend
NK1.1-PE Mouse IgG2a, kappa BioLegend
CD11b-eFluro450 Rat IgG2b, kappa eBioscience
CD3-eFluro450 Rat IgG2b, kappa eBioscience
F4/80-APC Rat IgG2a, kappa eBioscience
7-Amino-actinomycin D
(7AAD)
Invitrogen
Panel 2 divided lymphocytes into: B cells (CD19+) and T cells
(CD3+). T cells were then further subdivided into CD4+ T cells,
CD8+ T cells, CD4−CD8− T cells, and CD4+CD25+ T cells.
Fluorescence-minus-one were included as negative controls to
define positive populations for F4/80, CD11c, Ly6C, CD19, CD3,
and CD25.
CYTOKINE MEASUREMENT
Single-cell suspensions of brain, blood and spleen were obtained
as described for flow cytometry. All cells were resuspended in
complete RPMI 1640 media supplemented with heat inacti-
vated fetal bovine serum (10% w/v), streptomycin and penicillin
(100 U/mL), L-glutamine (1%) and 2-mercaptoethanol (50mM).
Blood and spleen cells were seeded at 200,000 cells/well in a 96-
well plate coated with anti-CD3. All cells in the brain hemisphere
were seeded. Blood, spleen, and contralateral brain hemisphere
of sham-operated mice was seeded as unstimulated controls.
Recombinant mouse IL-2 (20 ng/mL) was added and cells were
incubated for 48 h at 37◦C in a humidified atmosphere of 5%
CO2 in air. After stimulation, cells were spun down (15,000 rpm,
5min) and supernatant was collected. Samples were analyzed for
7 key inflammatory cytokines (IL-4, IL-6, IL-10, IL-17A, IFN-γ,
and TNF-α) using Cytometric Bead Array Mouse Th1/Th2/Th17
Cytokine kit (BD Biosciences, Franklin Lakes, NJ, USA). Samples
and standards were prepared according to manufacturer’s proto-
col. After adding capture beads, cells were analyzed by LSRII flow
cytometer (BD Biosciences, Franklin Lakes, NJ, USA) and FCAP
Array software (BD Biosciences, Franklin Lakes, NJ, USA).
STATISTICAL ANALYSIS
Values are presented as mean ± standard error. Results of the
hanging wire test, infarct volume and flow cytometry, comparing
C57Bl/6 and FVB sham- or stroke-operated mice, were analyzed
using one-way analysis of variance with Bonferroni post-hoc test
with selected multiple comparisons or a Student’s unpaired t-test,
as appropriate. The neurological deficit score was expressed as the
median result per group and was analyzed using a Kruskal-Wallis
test with Dunn’s post-hoc test. A P value <0.05 was considered
statistically significant. Statistical analyses were carried out using
GraphPad Prism (GraphPad Software Inc, La Jolla, CA, USA).
RESULTS
CEREBRAL BLOOD FLOW PROFILE AND MORTALITY
CBF was similarly reduced by ∼80% in both C57Bl/6 and FVB
mice following insertion of the monofilament (Figure 1A). No
significant differences in CBF profiles were observed between
C57Bl/6 and FVB mice. Mortality rates at 24 h after cerebral
ischemia were 8.8% (3/34) and 2.9% (1/34) in C57Bl/6 and FVB
mice, respectively (Figure 1B). Mice of both strains had no sig-
nificant differences in the cerebrovascular anatomy; in particular,
the posterior communicating arteries were present in both strains
(Supplementary Figure 1).
NEUROLOGICAL FUNCTION
Mice of both strains typically had no neurological deficit (score
of 0) at 24 h after sham surgery (Figure 1B). Following cere-
bral ischemia, both C57Bl/6 and FVB mice had significant
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FIGURE 1 | (A) Regional cerebral blood flow during 1 h middle cerebral
artery occlusion (n = 30–31); (B) neurological deficit (n = 29–34;
∗∗P < 0.01, ∗∗∗P < 0.001; Kruskal-Wallis with Dunn’s post-tests) and (C,D)
hanging wire performance (n = 28–33; ∗∗P < 0.01; Student’s unpaired
t-test) at 24 h after cerebral ischemia. There was less functional impairment
in FVB mice compared to C57Bl/6 mice. Data are mean ± s.e.m. in (A,C,D),
and are median scores in (B).
neurological deficit compared to sham-operated mice of the
same strain, although C57Bl/6 mice had greater deficit than FVB
mice. Similarly, in the hanging wire test sham-operated C57Bl/6
and FVB mice achieved comparable hanging times (Figure 1C),
whereas FVB mice achieved ∼2-fold longer hanging times than
C57Bl/6 mice at 24 h following cerebral ischemia (Figure 1D).
INFARCT AND EDEMA VOLUMES
Representative coronal sections of C57Bl/6 and FVB brains at
24 h afterMCA occlusion are shown in Figures 2A,B, respectively.
C57Bl/6 and FVB mice had similar total infarct (Figure 2C),
cortical infarct (Figure 2E), subcortical infarct (Figure 2F) and
edema (Figure 2D) volumes.
LEUKOCYTE INFILTRATION IN THE BRAIN
There was a ∼4-fold increase in the total number of leuko-
cytes in the ischemic hemisphere of C57Bl/6 mice compared to
sham-operated mice (P < 0.01, Figure 3A). There also tended
to be an increase in total leukocytes following ischemia in
FVB mice, but there were ∼40% fewer leukocytes than in
C57Bl/6 mice (Figure 3A). Myeloid cells (CD11b+), compris-
ing neutrophils (Ly6G+), dendritic cells (CD11b+CD11c+),
macrophages (F4/80+) and monocytes (Ly6C+), were increased
by a ∼15-fold in the ischemic hemisphere of FVB mice to lev-
els that were twice those in C57Bl/6 mice (P < 0.01, Figure 3B).
By contrast, lymphoid cells were increased by 2–3-fold following
ischemia in C57Bl/6 mice, whereas there was no change in lym-
phoid cell numbers in the brains of FVB mice following stroke
(Figure 3C). No significant effect of stroke was observed in the
number of microglia (CD45+medCD11b+F4/80+) in either strain
(Figure 3D).
Among myeloid cells, neutrophils were most prevalent, with
these cells being ∼4-fold more numerous in ischemic hemi-
spheres of FVB than in C57Bl6 mice (Figure 4A). There was a
similar profile of both macrophage and Ly6Clow monocyte num-
bers in the ischemic brain following stroke, with also ∼4-fold
more of these cells in FVB than C57Bl/6 mice (Figures 4B,C).
Ly6Chigh monocytes and total monocytes were present in similar
numbers in the ischemic brains of the two strains (Figures 4D,E).
In contrast, the number of dendritic cells in the ischemic hemi-
sphere was∼3-fold higher in C57Bl/6 than FVBmice (Figure 4F).
Among lymphoid cells, there were marked increases in num-
bers of both B cells and T cells in the post-ischemic brain of
C57Bl/6 mice but not FVB mice (Figures 5A,B). Further analy-
sis of T cell subpopulations indicated that the increase in C57Bl/6
mice was mostly due to infiltration of CD4+CD25− (“T helper”)
cells and not to CD8+ (“cytotoxic”) nor CD4+CD25+ T cells,
which includes Tregs (Figures 5C–E).
Overall, despite similar compositions of immune cells in
the brains of C57Bl/6 and FVB mice following sham surgery,
there were marked differences between strains after stroke with
lymphoid:myeloid cells representing ∼80:20 in total (Figure 6).
While a similar ratio persisted in C57Bl/6 mice after ischemia,
there was a markedly different leukocyte composition in FVB
mice after stroke, with a reversal of the lymphoid:myeloid ratio
to ∼20:80 (Figure 6). There were few differences in blood com-
position of leukocytes between strains or after stroke (Figure 7).
SPLENIC LEUKOCYTE NUMBERS
At 24 h after stroke there was a tendency for a reduction in
the total number of splenic leukocytes in both mouse strains
(Figure 8A). There were fewer splenic myeloid cells in FVB
vs. C57Bl/6 mice, due to lower numbers of neutrophils and
Ly6Chigh monocytes (Figures 8B,D,G), whereas there were higher
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FIGURE 2 | Representative coronal brain sections from a (A) C57Bl/6
mouse and a (B) FVB mouse 24h after 1 h middle cerebral artery
occlusion (infarct areas are outlined in white). Infarct [(C), total; (D),
cortical; (E), subcortical] and (F) edema volumes are also shown (n = 11 per
group; Student’s unpaired t-test). There was no difference in the infarct
volume between two strains of mice. Data are mean ± s.e.m.
numbers of CD4+, CD8+, and total T cells in that strain
(Figures 8J–L). There was no significant reduction in any cell
population (Figures 8C,E,F,H,I) except for 40–50% fewer T cells
in FVB mice (Figures 8J–L). Consistent with these data, spleen
weight was slightly reduced at 24 h after stroke in both strains,
with the difference reaching statistical significance in FVB mice
only (Supplementary Figure 2).
CYTOKINE LEVELS
Brain cytokine analysis at 24 h indicated that stroke resulted in
substantially higher mean levels of IL-4, IL-6, TNF-α, IFN-γ, IL-
10, and IL-17A in both C57Bl/6 and FVB mice (Supplementary
Figure 3). There was a tendency for higher levels of IL-4, IL-6,
TNF-α, and IFN-γ in the ischemic hemisphere of FVB than of
C57Bl/6 (Supplementary Figure 3). There were no clear trends
in cytokine levels in blood and spleen were generally simi-
lar in sham-operated mice of each strain, and there were no
marked effects of stroke after 24 h in either strain (Supplementary
Figures 4, 5).
DISCUSSION
There is growing evidence that T lymphocytes may influence
the development of ischemic injury and functional deficit fol-
lowing experimental stroke (Iadecola and Anrather, 2011; Brait
et al., 2012). For example, mice lacking T cells are reported
to have smaller infarcts and improved functional outcome after
focal ischemia compared to wild-type mice (Yilmaz et al., 2006;
Hurn et al., 2007; Urra et al., 2009a; Kleinschnitz et al., 2013).
Furthermore, there may be differential effects of CD4+ T cell
subsets on stroke outcome, such as exacerbation by Th1 cells
and amelioration by Th2 cells of brain infarct development and
functional deficit (Xiong et al., 2011; Gu et al., 2012). There is
also clinical evidence that single nucleotide polymorphisms in
the genes of Th1 and Th2 cytokines, and molecules that regulate
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FIGURE 3 | Flow cytometric quantification of (A) total leukocytes and
(B–D) leukocyte subsets in the brain at 24h after 1 h middle cerebral
artery occlusion. Data are shown for the contralateral and ischemic
hemispheres, and compared with sham control mice of the same strain (n
values: total leukocytes n = 13–16, subsets n = 6–9; ∗P < 0.05, ∗∗P < 0.01;
One-Way ANOVA with Bonferroni post-tests). There was a greater number of
leukocytes, predominantly lymphoid cells, infiltrating the brain of C57Bl/6
mice compared to FVB mice. Data are mean ± s.e.m.
FIGURE 4 | Quantification of myeloid cell subpopulations [(A),
neutrophils; (B), macrophages; (C), Ly6C low monocytes; (D),
Ly6C high monocytes; (E), monocytes; (F), dendritic cells] in
the brain 24h after 1 h middle cerebral artery occlusion. Data
are shown for the contralateral and ischemic hemispheres, and
compared with sham control animals of the same strain (n = 6–9;
∗P < 0.05, ∗∗P < 0.01; One-Way ANOVA with Bonferroni post-tests).
Data are mean ± s.e.m.
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FIGURE 5 | Quantification of lymphocyte subpopulations [(A), B cells; (B),
T cells; (C), CD4+ T cells; (D), CD4+ CD25+ T cells; (E), CD8+ T cells] in the
brain 24h after 1 h middle cerebral artery occlusion. Data are shown for the
contralateral and ischemic hemispheres, and compared with sham control
animals of the same strain (n = 4–8; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001;
One-Way ANOVA with Bonferroni post-tests). Data are mean ± s.e.m.
their transcription rate or their functionality, may predispose to
immune responses of differing strength and thus contribute to the
risk of stroke (Marousi et al., 2008).
Our study has examined representative mouse strains com-
monly accepted as Th1-dominant (C57Bl/6) and Th2-dominant
(FVB) (Whitehead et al., 2003) to investigate stroke outcome at
24 h in prototypical Th1- vs. Th2-prone immune environments,
respectively. Our data generally support the concept that Th1-
prone immunity in C57Bl/6 results in a more severe functional
outcome after stroke compared to Th2-prone FVB mice. For
example, spleen levels of IL-4 and IL-10 were 3–4-fold higher
in control FVB vs. C57Bl/6 mice. Yet, with no significant dif-
ferences in cerebrovascular anatomy, degree of ischemic insult
caused byMCA occlusion, and ultimately in the developed infarct
size between the twomouse strains, there was amarkedly different
profile of immune cell infiltration in the ischemic hemispheres of
C57Bl/6 and FVB mice.
Despite a similar immune cell composition in the brains of
sham-operated C57Bl/6 and FVBmice, which comprised myeloid
and lymphoid cells in a ∼20:80 ratio, after ischemia there was
an overall increase in infiltrating cell numbers in both strains
whereby this ratio was preserved in C57Bl/6 but was converted
to ∼80:20 in FVB mice. The magnitude of total leukocyte infil-
tration into the brain of C57Bl/6 was approximately twice that
observed in FVB, and these strain differences occurred in the
absence of any notable stroke-related systemic differences such
as cell numbers, cell composition or cytokine profile in either
blood or spleen. Striking increases were noted to occur particu-
larly in the number of innate immune cells such as neutrophils,
macrophages and LyC6+low monocytes infiltrating the ischemic
FVB brain, whereas the most prominent increases in C57Bl/6
mice occurred in the numbers of infiltrating T and B lympho-
cytes and dendritic cells—key cells for adaptive immunity. These
responses were associated with some strain differences in the
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FIGURE 6 | Pie charts summarizing number and composition of
immune cells in ischemic hemispheres of C57Bl/6 and FVB mice at
24h after 1 h middle cerebral artery occlusion. The area of each pie is
proportional to the number of leukocytes per hemisphere (also shown as
mean ± s.e.m.; total leukocytes n = 13–16, myeloid cells n = 6–9,
lymphocytes n = 4–8). There was a greater number of leukocytes,
predominantly lymphoid cells, infiltrating the brain of C57Bl/6 mice
compared to FVB mice.
mean levels of certain cytokines in the ischemic hemisphere, such
as a tendency for larger amounts of both Th1 (IFN-γ, TNF-α)
and Th2 (IL-4, IL-6) cytokines to be present in FVB than C57Bl/6
mice. However, it is not possible from the present data to dis-
cern whether these differences in brain cytokine levels may have
been a cause or effect of the different post-ischemic immune cell
profiles.
We found marked differences in neutrophil content of
ischemic brains between FVB and C57Bl/6 mice. Clinical and
experimental data suggest that neutrophils are the most abun-
dant cell type in the brain after ischemia (Akopov et al., 1996;
Gelderblom et al., 2009; Chu et al., 2014) and their accumulation
is correlated with the severity of brain infarct and neurologi-
cal deficit (Akopov et al., 1996). Activated neutrophils have been
shown to promote the release of free radicals and cytokines, which
further recruit leukocytes to the damaged area (Harris et al.,
2005). However, it is controversial whether neutrophils contribute
directly to secondary brain damage or have a mild neuroprotec-
tive role in cerebral ischemia. Animal studies have shown that
increased infarct size is associated with neutrophil elimination
(Takizawa et al., 2002) whilst others have shown that neutrophils
may not contribute directly to infarct size (Beray-Berthat et al.,
2003; Harris et al., 2005; Brait et al., 2011). Our data in FVB
mice suggest that neutrophil number is not directly associated
with infarct size in that a ∼100-fold increase in brain infiltra-
tion after ischemia did not result in a bigger infarct size than
in C57Bl/6 mice where the increase was markedly less. In previ-
ous study of parasite infection, neutrophils were found to play
an early role in the induction of the Th2 response that develops
in Th2-prone Balb/C mice but not in C57Bl/6 mice (Tacchini-
Cottier et al., 2000). Thus, it is possible that the infiltration of
neutrophils into the ischemic brains of FVB mice was associated
with the induction of a less severe Th2-type immune response.
There were also markedly greater numbers of macrophages
and Ly6Clow monocytes (the latter are considered to be anti-
inflammatory) present in the FVB brains after cerebral ischemia.
Macrophages and monocytes produce inflammatory cytokines
and upregulate adhesion molecules in endothelial cells, thereby
promoting neutrophil accumulation and migration (Chiba and
Umegaki, 2013). Analogous to Th cells, macrophages are
highly plastic cells and can polarize into two distinct activated
macrophage subsets depending on the microenvironment (Kigerl
et al., 2009). The classic or M1 activated cells are characterized by
their capacity to present antigen, high production of nitric oxide
and reactive oxygen species and of pro-inflammatory cytokines.
In contrast, alternative or M2 activated cells are involved in
scavenging of debris, angiogenesis, tissue remodeling and repair
(Kigerl et al., 2009). Macrophages from Th1 strains (e.g., C57Bl/6,
B10D2) are known to be more readily activated (e.g., to produce
nitric oxide) than macrophages from Th2 strains (e.g., Balb/C,
DBA/2) (Mills et al., 2000). Ly6C+low monocytes are known
to exhibit M2 characteristics (Geissmann et al., 2010). At the
early stages following ischemic stroke, resident microglia and
newly recruited macrophages appear to have a M2 phenotype
that gradually transforms into an M1 phenotype in peri-infarct
regions (Hu et al., 2012). It is possible that the greater num-
ber of macrophages and Ly6C+low monocytes in FVB mice at
24 h after stroke represents more numerous M2-like cells con-
tributing to a milder inflammatory environment in that strain.
Further insight into the polarity of macrophages in FVB mice is
needed.
We observed an increase in dendritic cells in the ischemic
brain of C57Bl/6 mice at 24 h. Dendritic cells are involved in
antigen presentation during immune cell activation and in the
maintenance of peripheral tolerance through modulation of the
immune response (Thompson and Thomas, 2002), but their role
in outcome after cerebral ischemia is currently unclear.
There was a marked infiltration of lymphoid cells, particularly
B and CD4+ T cells (i.e., Th cells), into the ischemic hemi-
sphere of C57Bl/6 mice. T lymphocytes enter the brain by 24 h
after ischemic stroke (Gelderblom et al., 2009; Kleinschnitz et al.,
2013; Chu et al., 2014), and both CD4+ and CD8+ T cells con-
tribute to post-ischemic injury in mice (Arumugam et al., 2005;
Kleinschnitz et al., 2013). It is conceivable that the infiltration of
CD4+ cells, which occurred selectively in C57Bl/6 mice following
stroke, contributed to a more severe level of brain inflamma-
tion than in FVB mice despite a similar infarct volume. Tregs
are a subset of CD4+ T cells that are reported to play a protec-
tive, immunomodulatory role in the brain over several days after
stroke (Liesz et al., 2009), but a detrimental role during more
acute conditions (Kleinschnitz et al., 2013). We found no signifi-
cant changes after stroke in either CD8+ cells or CD4+CD25+ T
cells, which will largely consist of Tregs.
Effects of B cells on stroke outcome are poorly understood.
B cells can function as antigen-presenting cells to activate cyto-
toxic CD8+ T cells, but there is also data to suggest that an
IL-10-producing subpopulation of regulatory B cells may limit
injury in experimental stroke (Ren et al., 2011; Bodhankar
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FIGURE 7 | Quantification of (A) total leukocytes and (B–L) leukocyte
subsets in blood 24h after 1 h middle cerebral artery occlusion,
compared with sham control animals of the same strain (total
leukocytes n = 16–28, myeloid cells n = 9–17, lymphocytes n = 7–12;
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001; One-Way ANOVA with Bonferroni
post-tests). Data are mean ± s.e.m.
et al., 2013). In addition, poor outcome in stroke patients is
associated with reduced levels of circulating B cells (Urra et al.,
2009b). Interestingly, we found that B cell infiltration into the
brain following ischemia occurred selectively in C57Bl/6 mice
(Figure 5A). Furthermore, whereas the number of circulating B
cells was ∼5-fold higher in control C57Bl/6 vs. FVB mice, stroke
selectively reduced the number of B cells in the blood of the
former strain (Figure 7I). Further study is necessary to clarify
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FIGURE 8 | Quantification of (A) total leukocytes and (B–L) leukocyte
subsets in spleen 24h after 1 h middle cerebral artery occlusion,
compared with sham control animals of the same strain (total
leukocytes n = 17–29, myeloid cells n = 9–17, lymphocytes n = 6–12;
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001; One-Way ANOVA with Bonferroni
post-tests). Data are mean ± s.e.m.
the importance of these strain differences in B cell number and
distribution for stroke outcome.
In summary, we observed a profound difference in post-
stroke functional outcome which was associated with a markedly
contrasting number and composition of cells infiltrating the
injured brain, despite similar systemic immune cell and cytokine
profiles between the twomouse strains. The data therefore suggest
that the nature of the inflammatory response to brain ischemia
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can vary considerably, and it may consequently impact the func-
tional outcome independently of the volume of injured tissue. It
would appear that the early infiltration into the ischemic brain
tissue of certain innate/myeloid cell types, such as neutrophils,
macrophages and Ly6C+low monocytes, rather than cells of the
adaptive immune system, such as B and T lymphocytes, may assist
in achieving a milder level of functional deficit.
We acknowledge that while differences in biological responses
between mouse strains that possess varying genetic and immuno-
logical profilesmay provide a useful tool to gain somemechanistic
insight into immune cell-mediated ischemic brain injury, studies
of mice of the same genetic background are needed to pro-
vide definitive conclusions regarding these complex mechanisms.
Moreover, if such findings are relevant for developing effective
therapies for stroke patients, it will be interesting to determine
whether individuals predisposed to Th2-prone immunity, includ-
ing conditions such as asthma and allergy, might experience
milder brain inflammation and functional deficit after stroke.
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